STOCK TITAN

AlphaTON Capital Corp Stock Price, News & Analysis

ATON Nasdaq

Welcome to our dedicated page for AlphaTON Capital news (Ticker: ATON), a resource for investors and traders seeking the latest updates and insights on AlphaTON Capital stock.

AlphaTON Capital Corp (NASDAQ: ATON) generates news at the intersection of technology, digital assets, decentralized AI infrastructure, and advanced healthcare. The company describes itself as a public technology company scaling the Telegram super app while managing a strategic reserve of digital assets and building exposure to The Open Network (TON) ecosystem. Its announcements often combine capital markets activity with updates on AI compute deployments, Telegram-based applications, and tokenization initiatives.

Readers following ATON news can expect frequent coverage of financing transactions such as private placements, at-the-market offerings, and registered direct offerings supported by shelf registration statements. These items detail how AlphaTON raises capital to fund GPU deployments for Cocoon AI, expand data center capacity, and support working capital and general corporate purposes.

Another major category of AlphaTON news involves decentralized AI infrastructure. The company has issued multiple releases about securing and deploying NVIDIA H200, B200 and B300 GPUs, entering into a multi-year colocation agreement with atNorth in Sweden, and contributing confidential compute power to Telegram’s Cocoon AI network. These updates describe how AlphaTON is building privacy-preserving, decentralized AI infrastructure integrated with Telegram’s ecosystem.

News items also cover strategic investments and ecosystem partnerships, including investment in Alpha Liquid Terminal, plans for tokenized financial products, and initiatives like the #OwnYourNode program that aim to democratize GPU ownership. In addition, AlphaTON reports on its legacy biotech activities and its intention to launch a decentralized, AI-native biotech platform for rare cancers, starting with mesothelioma.

For investors and observers, the ATON news feed offers a way to track how the company combines digital asset treasury management, AI infrastructure build-out, Telegram-based financial applications, and biotech-related initiatives under a single Nasdaq-listed entity.

Rhea-AI Summary

AlphaTON (Nasdaq: ATON) and its oncology subsidiary Cyncado Therapeutics announced a non-binding Letter of Intent with Australia’s Asbestos and Dust Diseases Research Institute (ADDRI) to run an investigator-initiated trial of TT-4, a selective A2B receptor antagonist, in mesothelioma on Nov 12, 2025.

The ADDRI-sponsored study is planned to enroll approximately 50 patients, will be led by A/Prof Steven Kao and Dr Melvin Chin, and will run alongside Cyncado’s planned U.S. mesothelioma activities, subject to a definitive agreement and customary approvals. Cyncado will provide TT-4 and limited support. The trial targets second-line/after first-line settings where options remain limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.99%
Tags
-
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) appointed William De’Ath as Chief Partnership Officer on November 11, 2025 to lead global partnerships, institutional adoption, M&A sourcing, and the rollout of the TON Mastercard. The TON Mastercard will be developed with partners Pago Pay and ALT5 Sigma. De’Ath brings 30+ years of commercial strategy experience across Fortune 500s, blockchain custody integrations (including Taurus SA for major banks), AI ventures, and a reported $28M ARR delivery at PETRONAS. His remit includes ecosystem expansion across DeFi, gaming, and mini-app infrastructure and coordinating commercial diligence for revenue-generating deals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.9%
Tags
partnership
-
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) and subsidiary Cyncado Therapeutics reported preclinical results showing that co‑administration of selective adenosine A2B antagonist TT-4 and A2A antagonist TT-10 with antigen-specific cancer vaccines produced strong antitumor effects in three mouse models.

The triple combination (TT-4 + TT-10 + vaccine) significantly suppressed tumor growth, improved survival, elicited intratumoral CD8+ T-cell responses, produced complete tumor regressions in several mice, and conferred resistance to tumor rechallenge. Data were presented at SITC on November 8, 2025. Clinical status: TT-10 is in Phase 1 dose escalation and TT-4 is IND-enabled and preparing for first‑patient dosing in Q1 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.16%
Tags
none
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) announced definitive terms to acquire Blockchain Wire, a press release distribution service for blockchain, crypto, and digital asset sectors. Blockchain Wire reports >100% CAGR since 2023, is profitable, and serves 4,000+ clients. AlphaTON plans to integrate Blockchain Wire into its ecosystem and launch the world's first verifiable newswire on The Open Network (TON), using cryptographic time-stamping and Telegram mini-apps to verify and trace press releases. The acquisition is expected to close in Q1 2026, subject to customary closing conditions, and Blockchain Wire will become a wholly owned subsidiary.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
-
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) announced that CEO Brittany Kaiser will speak on a high-profile panel at SALT London 2025, taking place November 5–8, 2025. The panel is titled “New Access Points: DeFi, Tokenization, and Digital Asset Treasuries (DATs)” and will be moderated by Camilla McFarland, Chief Growth Officer at The Ether Machine.

Panelists include Patrick Horsman (CIO, BNBX), Michael Healy (Co-founder, Unit Network), and Henry K. Elder (CEO, Satsuma Technology). The session will explore institutional access, tokenized assets, decentralized finance, and implications for capital markets and Web3 adoption, including references to the TON network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.2%
Tags
crypto conferences
-
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) announced a joint venture with PagoPay, ALT5 Sigma (Nasdaq: ALTS) and World Liberty Financial to launch a TON Mastercard payment card program enabling native TON, USD1 and other crypto spending directly from digital wallets.

The program will offer physical and virtual cards for U.S. and international use, use ALT5 for crypto-to-fiat conversion, grant AlphaTON exclusive marketing/distribution rights, include an option for AlphaTON to acquire 100% operational control and contemplate PagoPay equity participation. Parties expect definitive agreements within 30 days and target initial card production about 90 days after Mastercard approval, subject to regulatory compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.2%
Tags
partnership
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) announced CEO Brittany Kaiser and senior leaders will participate in the TRUST Summit 2025 hosted by Hacken at Nasdaq MarketSite in New York on Nov. 3, 2025.

The invite-only forum gathers about 100 policymakers, institutional investors, and cybersecurity experts to discuss secure, scalable blockchain adoption, decentralized AI, and data-rights frameworks. The event is part of AlphaTON’s 2025 Global Tour, following Washington D.C. meetings and preceding stops in London, Lisbon, Abu Dhabi, Miami, and Davos.

AlphaTON said the summit aims to align trust, compliance, privacy, and security across regulators and institutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.2%
Tags
none
-
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) is launching a global World Tour with an Investor Breakfast at the Nasdaq MarketSite in New York on November 3, 2025. Speakers include Brittany Kaiser (CEO), Enzo Villani (Chairman & CIO) and Michael Terpin (independent board member).

AlphaTON says it raised $71 million to accelerate a global strategy as the first TON Digital Asset Treasury (DAT) focused on M&A and ecosystem investments, with stated expansion into gaming, DeFi and broader Web3 accessibility via Telegram’s user base.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.99%
Tags
none
-
Rhea-AI Summary

AlphaTON Capital (Nasdaq: ATON) announced plans on Oct 29, 2025 to invest in enterprise GPU and data center infrastructure to support Cocoon, the Confidential Compute Open Network unveiled by Telegram founder Pavel Durov. AlphaTON said it will deploy next‑generation, high‑memory GPUs across strategic data centers to provide high uptime and capacity for private AI inference, supporting model architectures such as DeepSeek and Qwen. Telegram will be Cocoon's first major customer and the network is scheduled to launch in November 2025 after onboarding developers and GPU providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.36%
Tags
AI
Rhea-AI Summary

AlphaTON Capital (NASDAQ: ATON) announced that CEO Brittany Kaiser will be a featured speaker at the Future of Money, Governance, and the Law summit on Capitol Hill on October 30, 2025.

The summit, hosted by the Government Blockchain Association and The Edge Of Company, will convene policymakers, industry leaders, and innovators to discuss digital assets, governance, digital identity, tokenized ecosystems, and regulatory frameworks. Kaiser will speak on responsible innovation, digital identity, and how tokenized systems can empower individuals, reflecting AlphaTON’s focus on investments in early-stage blockchain and AI ventures that emphasize transparency and data sovereignty.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
conferences

FAQ

What is the current stock price of AlphaTON Capital (ATON)?

The current stock price of AlphaTON Capital (ATON) is $0.512 as of February 9, 2026.

What is the market cap of AlphaTON Capital (ATON)?

The market cap of AlphaTON Capital (ATON) is approximately 7.1M.
AlphaTON Capital Corp

Nasdaq:ATON

ATON Rankings

ATON Stock Data

7.14M
11.93M
60.57%
4.17%
1.59%
Asset Management
Financial Services
Link
British Virgin Islands
Tortola

ATON RSS Feed